48 results
424B5
ALRN
Aileron Therapeutics Inc
1 May 24
Prospectus supplement for primary offering
5:24pm
and that the warrants are classified as and accounted for as equity), you will experience immediate and substantial dilution of $3.77 per share … hereby and that the warrants are classified and accounted for as equity), our pro forma as adjusted net tangible book value as of December 31, 2023 would
8-K
ALRN
Aileron Therapeutics Inc
25 Jan 24
Other Events
7:00am
restrict the use and dissemination outside of the U.S., or the sharing with
certain non-U.S. nationals, of information products classified … by making it more difficult for stockholders to replace members of our board of directors. Among other things, these provisions:
establish a classified
8-K/A
EX-99.3
j09nbudtj 45vh0z
11 Jan 24
Index to Consolidated Financial Statements
4:18pm
8-K/A
EX-99.1
qfm dqa0xzt
11 Jan 24
Index to Consolidated Financial Statements
4:18pm
8-K/A
EX-99.2
u5s9en5xq0tvxp6e2ytd
11 Jan 24
Index to Consolidated Financial Statements
4:18pm
8-K
EX-10.1
g9o xdgfjog8
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm
8-K
EX-2.1
ixfti59u
31 Oct 23
Aileron Therapeutics Announces Acquisition of Lung Therapeutics
12:40pm